Be part of the knowledge.™

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

882

LikeLikedUnlike

Episodes 91-105 of 181

NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
On the Frontlines of Non-Small Cell Lung Cancer
NSCLC Care: Predicting Response to Dato-DXd with a TROP2 Biomarker
- Jacob Sands, MD
  Peer
- Marina Garassino, MD
  Peer
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Project Oncology®
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Hannah McManus, MD
  Peer
- Andrew Armstrong, MD, MSc
  Peer
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
CME/CE
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
- Jennifer Caudle, DO
  Peer
- Patricia A. Mangan, RN, MSN, APRN-BC
  Peer
0.25 credits
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Project Oncology®
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
- Jesus G. Berdeja, MD
  Peer
- Nicholas G. Barkemeyer, MPAS
  Peer
- Ajai Chari, MD
  Peer
- Harvey Church
  Peer
- Amy Gebhardt
  Peer
- Steven Morrow
  Peer
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
Project Oncology®
Navigating NUT Carcinoma: Diagnosis and Treatment Strategies
- Jacob Sands, MD
  Peer
- Jia Luo, MD
  Peer
Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
Project Oncology®
Optimizing Quality & Safety Systems to Reduce the Risk of Patient Harm
- Jacob Sands, MD
  Peer
- Joseph O. Jacobson, MD
  Peer
advertisement
Managing Immunotherapy Toxicities in Lung Cancer Patients
Spotlight on Lung Cancer
Managing Immunotherapy Toxicities in Lung Cancer Patients
- Jacob Sands, MD
  Peer
- Aliyah Pabani, MD
  Peer
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CE
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
- Mario Cozzolino, MD, PhD
  Peer
- Jan T. Kielstein, MD, FASN, FERA
  Peer
Exploring New Frontiers in Cervical Cancer Screening
Advances in Women's Health
Exploring New Frontiers in Cervical Cancer Screening
- Jennifer Caudle, DO
  Peer
- Diane M. Harper, MD, MPH, MS
  Peer
Recognizing the Role of Capmatinib for METex14 in NSCLC
Project Oncology®
Recognizing the Role of Capmatinib for METex14 in NSCLC
- Jacob Sands, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
HER3-Directed ADCs in Breast Cancer
MinuteCE®
HER3-Directed ADCs in Breast Cancer
- Sara A. Hurvitz, MD, FACP
  Peer
HER3-Directed ADCs in Lung Cancer
MinuteCE®
HER3-Directed ADCs in Lung Cancer
- Justin Gainor, MD
  Peer
advertisement
HER2-Directed ADCs in Lung Cancer
MinuteCE®
HER2-Directed ADCs in Lung Cancer
- Justin Gainor, MD
  Peer
TROP2-Directed ADCs in Breast Cancer
MinuteCE®
TROP2-Directed ADCs in Breast Cancer
- Sara A. Hurvitz, MD, FACP
  Peer
TROP2-Directed ADCs in Lung Cancer
MinuteCE®
TROP2-Directed ADCs in Lung Cancer
- Justin Gainor, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended